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Abstract 
Background: Prior studies of physical functioning after critical illness have been mostly limited to survivors of acute 
respiratory distress syndrome. The purpose of this study was to objectively assess muscle strength and physical 
functioning in survivors of critical illness from a general ICU and the associations of these measures to health-related 
quality of life (HRQL), mental health and critical illness variables.
Methods: This was a prospective cohort study of 56 patients admitted to a medical ICU (length of stay ≥4 days) 
from April 1, 2009, and March 31, 2010. Patients were assessed in clinic at 3 months post-hospital discharge. Muscle 
strength and physical functioning were measured using hand-held dynamometry and the 6-min walk test. HRQL was 
assessed using the short-form 36 (SF-36) and EuroQol-5D (EQ-5D) questionnaires.
Results: Three months post-hospital discharge, median age- and sex-matched muscle strength was reduced across 
all muscle groups. The median 6-min walk distance was 72 % of predicted. Physical functioning was associated with 
reductions in self-reported HRQL (SF-36, EQ-5D) and increased anxiety. Univariate regression modeling showed that 
reduced muscle strength and 6-min walk distance were associated with sepsis but not ICU length of stay. Multivariate 
regression modeling showed that sepsis and corticosteroid use were associated with a reduced 6-min walk distance, 
but again ICU length of stay was not.
Conclusions: Survivors of critical illness have reduced strength in multiple muscle groups and impaired exercise 
tolerance impacting both HRQL and mental health. These outcomes were worsened by sepsis and corticosteroid 
use in the ICU but not ICU length of stay. Interventions to minimizing the burden of sepsis in critically ill patients may 
improve long-term outcomes.
Keywords: Critical care, Muscle weakness, Muscle strength dynamometer, Sepsis, Recovery of function, Adult
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
Background
As more patients are surviving critical illness, examining 
longer-term outcomes becomes increasingly important. 
There is increasing evidence that critical illness survivors 
have impaired physical functioning, increased prevalence 
of mental health disorders and reduced health-related 
quality of life (HRQL) [1–6].
Critically ill patients have been shown to develop mul-
tifactorial weakness termed ICU-acquired weakness 
(ICUAW), and these patients are at risk of prolonged 
ICU lengths of stay, increased mechanical ventilation 
time, prolonged weakness and poor hospital outcomes 
[7–13]. Muscle biopsies taken during critical illness 
have shown wasting of the muscle fibers and increased 
catabolic metabolism [14–17]. Risk factors for ICUAW 
include prolonged immobility, mechanical ventilation, 
corticosteroid and neuromuscular blockade administra-
tion and cytokine-related injury from systemic inflamma-
tion [5, 7, 9, 10, 17–24]. However, the duration of physical 
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impairment after hospital discharge secondary to critical 
illness and the predictors of severity remain unclear.
Studies that have objectively examined long-term phys-
ical function have primarily focused on survivors of acute 
respiratory distress syndrome (ARDS) and not the gen-
eral ICU survivor population. Long-term physical func-
tion of ARDS survivors was first objectively described by 
Herridge et al. [5] landmark paper using the 6-min walk 
test (6MWT). Recent post-ICU studies have used man-
ual muscle testing (MMT) for the assessment of muscle 
strength in addition to the 6MWT; however, MMT has 
limitations including a ceiling effect in less severe mus-
cle weakness [25, 26]. Isokinetic muscle strength testing 
using hand-held dynamometry has been shown to be a 
more sensitive and objective method of strength testing 
compared to MMT [25, 27–30]. However, to date hand-
held dynamometry has not been used in the ICU survi-
vor population, despite its common use in other patient 
populations [31–34].
The goal of our study was to objectively examine mus-
cle strength and physical functioning using hand-held 
dynamometry and the 6MWT in critical illness survi-
vors 3 months after hospital discharge. Additionally, we 
sought to determine whether muscle strength or physical 
functioning was associated with HRQL, mental health or 
critical illness variables such as severity and type of ill-
ness and ICU length of stay.
Methods
Design
This was a prospective longitudinal cohort study of 
patients who were admitted to a 25-bed multidisciplinary 
tertiary referral ICU, which also served as the trauma 
center for southern Alberta [35]. Enrollment occurred 
between April 1, 2009, and March 31, 2010. At the time 
of study enrollment, there were two full-time equivalent 
physiotherapists; however, no patients were mobilized 
while intubated in the ICU. The initiation of physiother-
apy was up to the discretion of the attending physician.
Patients assessed in the ICU follow-up clinic were adult 
patients (≥18  years), admitted to the ICU with a mini-
mum 4-day length of ICU stay. Patients were excluded 
if they had traumatic brain injuries, spinal cord injuries, 
pre-existing neurocognitive or neuromuscular disorders, 
acute strokes or lived outside of the immediate munici-
pality of Calgary. Patients in the ICU were screened for 
eligibility during the initial 48  h and approached for 
follow-up once they had been admitted to the ICU for a 
minimum of 4 days. Due to limited capacity in the ICU 
follow-up clinic, patients were enrolled consecutively 
until clinical capacity was met at which point screening 
would be temporally suspended. Patients enrolled in the 
ICU were assessed at 3 months after hospital discharge. 
A total of 61 patients met inclusion criteria, 4 patients 
declined follow-up, and 1 patient was lost to follow-up. 
Attendance at the clinic was presented as a natural con-
tinuation of care following hospitalization, which indi-
viduals had the option to refuse. We sought permission 
from these patients to include their clinical data in our 
study. This study was approved by the University of Cal-
gary Human Research Ethics Board (ID# E-22574), and 
written informed consent was obtained from all patients.
Instruments/questionnaires
A single trained individual (author KS) assessed periph-
eral muscle strength using hand-held dynamometry. 
The JAMAR (5030J1) hydraulic hand dynamometer and 
the Chatillon dynamometer (K-MSC-200) were used 
for all muscle strength assessments. All measurements 
were taken in kilograms to the nearest hundredth of a 
kilogram. Each muscle group (handgrip, triceps, biceps, 
ankle dorsiflexors, hamstrings and quadriceps) was 
measured according to previously validated protocols 
[36]. For each muscle group, patients were asked to exert 
a maximal effort for 3–4  s against the dynamometer, 
which was in a fixed position. Three measurements were 
collected for each muscle group, alternating between 
patient sides between measurements. For each muscle 
group, the highest force generated on the patient’s domi-
nant side was used for analysis. The National Isometric 
Muscle Strength Database Consortium [36] was used for 
age- and sex-standardized normative values. The 6MWT 
was used to assess overall physical functioning. Previ-
ously published guidelines and procedures were followed 
[37], and age and sex normative values were obtained 
from Enright et al. [38].
The assessment of HRQL was done using short-form 
36 (SF-36) and EuroQol-5D (EQ-5D) surveys [39]. The 
SF-36 survey was reported as each domain ranging from 
0 to 100 (higher scores indicate better HRQL), and the 
physical and mental composite scores (PCS, MCS) were 
standardized to Canadian population norms (score of 50 
represents the average normative value) [40]. The Hos-
pital Anxiety and Depression Scale (HADS) was used to 
assess anxiety and depression, scores ranging from 0 to 
21 [41]. A score >7 on either the anxiety or depression 
section indicates severe symptoms. All questionnaires 
were administered at the time of the patient’s clinical 
visit.
Statistical analysis
All clinical data were entered into a study-specific data-
base. These data were merged with clinical and out-
come data from an ICU-specific longitudinal database, 
details described elsewhere [42]. All data analysis was 
performed using Stata 11.0 (Stata Corp, College Station, 
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TX). Descriptive statistics were used to report patient 
demographics, hand-held dynamometry testing and the 
6MWT.
Multiple linear regression models were used to assess 
the association between the strength of each mus-
cle group (independent variable), 6MWT, EQ-5D and 
the SF-36 (dependent variables). The EQ-5D domains 
were modeled as a dichotomous variable (0 = no prob-
lems, 1  =  reporting any problems). Multiple univari-
ate and a single multivariate linear regression analysis 
assessed the association of the following ICU risk factors 
(dependent variables) to patient’s predicted peripheral 
muscle strength or 6MWT (independent variables): (1) 
ICU length of stay (LOS), (2) hospital LOS, (3) sever-
ity of illness as measured by the mean Acute Physiology 
and Chronic Health Evaluation (APACHE) II score, (4) 
degree of organ failure measure by the Sequential Organ 
Failure Assessment (SOFA) score, (5) presence of sepsis 
(defined using the 2001 American College of Chest Phy-
sicians guideline [43]), (6) presence of ARDS (defined 
as a PaO2:FiO2 ratio of 200 or less while mechanically 
ventilated with evidence of airspace disease in all four 
quadrants on chest radiograph), (7) any corticosteroid 
use, (8) any neuromuscular blocker use (9), duration of 
ventilation and (10) Functional Comorbidity Index score. 
For the multivariate linear regression, all ICU risk factors 
were analyzed in the model and variables that had a p 
value <0.05 were carried forward in the analysis to create 
the final model.
Results
During the study period, 56 patients were seen in the 
ICU follow-up clinic. The median (IQR) age was 61 years 
(41, 68), and 54  % were males (Table  1). Prior to ICU 
admission, 57  % of patients had one or more pre-exist-
ing comorbidity and 100  % were living independently 
at home. The median (IQR) first APACHE II score and 
maximum SOFA scores were 19 (16, 24) and 11 (9, 14), 
respectively. Only 18  % of patients received corticoster-
oids, and 21  % received neuromuscular blockers any-
time while in the ICU. No patient with ARDS received 
corticosteroids. The median (IQR) days of mechanical 
ventilation and ICU and hospital LOS were 8  days (4, 
11), 11 days (6, 15) and 12 days (8, 12), respectively. The 
median (IQR) time to follow-up was 72 days (54, 92) after 
hospital discharge.
Patient’s median dynamometry-measured muscle 
strength was reduced across all muscle groups when 
compared to age- and sex-matched data (Table  2). The 
median (IQR) percent-predicted strength of the hand-
grips 61  % (25, 108), quadriceps 59  % (35, 88) and the 
ankle dorsiflexors 62  % (42, 92) all showed the greatest 
impairment 3  months after critical illness. For all the 
muscle groups, over 50 % of the patients did not achieve 
80  % of their age- and sex-matched predicted strength. 
The median (IQR) distance walked in 6  min and per-
cent predicted were 382 m (291, 480) and 70 % (53, 88), 
respectively. In total, 55  % of patients did not achieve 
at least 80  % of their age- and sex-matched predicted 
6MWT distance. The maximum strength results of each 
muscle group statistically correlated with the 6MWT 
distance.
Table 3 outlines individual regression analyses evaluat-
ing the associations of physical functioning to HRQL and 
mental health. Reporting problems in the domains mobil-
ity (p = 0.003), usual activities (p = 0.006), pain and dis-
comfort (p = 0.031) of the EQ-5D were each associated 
with reduced predicted 6MWT distance. Patient’s overall 
impression of their global health using the EQ-5D VAS 
was also associated with performance on the 6MWT 
(p =  0.025). Among the muscle groups strength tested, 
Table 1 Baseline patient characteristics
ARDS acute respiratory distress syndrome, APACHE II Acute Physiology and 
Chronic Health Evaluation, SOFA Sequential Organ Failure Assessment, ICU 
intensive care unit
a Reported as median (interquartile range) unless specified
Variable All patients (n = 56)a
Baseline characteristics prior to admission
Age (year) 61 (41, 68)
Male [n (%)] 30 (54)
Pre-existing comorbidity [n (%)] 32 (57)
Charlson comorbidity index score 3 (1, 4)
Functional Comorbidity Index score 1 (0, 2)
Living independently at home [n (%)] 56 (100)
Body mass index (kg/m2) 26 (22, 33)
ICU characteristics
Diagnosis at ICU admission [n (%)]
 Respiratory failure 37 (66)
 Intra-abdominal infection 7 (13)
 Urologic infection 3 (5)
 Poly-trauma 4 (7)
 Other 5 (9)
Sepsis present during admission [n (%)] 39 (70)
ARDS present during admission [n (%)] 13 (23 %)
Any corticosteroid use [n (%)] 10 (18)
Daily dose corticosteroids if received any, mg 
(prednisone equivalent)
57 (35, 82)
Any neuromuscular blocker use [n (%)] 12 (21)
APACHE II score 19 (16, 24)
SOFA score maximum value 11 (9, 14)
Length of mechanical ventilation (day) 8 (4, 11)
Length of ICU stay (day) 11 (6, 15)
Length of hospital stay (day) 12 (8, 21)
Time to follow-up after hospital discharge (day) 72 (54, 92)
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grip (p =  0.030), hamstring (p =  0.021) and quadriceps 
(p  =  0.019) weakness were associated with increasing 
impairment on the mobility domain of the EQ-5D.
The physical function domain of the SF-36 was asso-
ciated with the percent-predicted 6MWT distance 
(p  <  0.001), grip strength (p  =  0.019) and hamstring 
strength (p = 0.026). The 6MWT percent-predicted dis-
tance was associated with the physical composite score of 
the SF-36 (p = 0.003) and the anxiety score of the Hospital 
and Anxiety Depression Scale. Patient’s percent-predicted 
6MWT and muscle strength for all muscle groups, except 
triceps, were statistically associated with reported val-
ues in the general health domain (patient’s perspective 
of overall health) of the SF-36. Additionally, patients pre-
dicted grip strength and 6MWT were associated with the 
vitality, social functioning and role emotional domains, 
with the 6MWT also associated with the physical role and 
emotional role domains (data not shown).
Table 2 Muscle strength and physical functioning of critical illness survivors at 3 months after hospital discharge meas-
ured using hand-held dynamometry and the 6-min walk test
6MWT 6-min walk test
a Strength results reported as the maximum force generated on the dominant body side
Variable (n = 56) Measurement (median, 
IQR)
% predicted (median, 
IQR)
% of patients < 80% predicted 
strength
Correlation with the 6MWT 
(R2, p value)
Maximum muscle strength (kg)a
 Grip 20.4 (9.1, 30.6) 61 % (25, 108) 60 0.28 (<0.001)
 Triceps 12.3 (8.7, 16.7) 71 % (45, 126) 52 0.31 (<0.001)
 Biceps 14.5 (11.7, 19.0) 72 % (45, 126) 52 0.28 (<0.001)
 Hamstrings 13.2 (10.3, 17.6) 77 % (47, 114) 53 0.30 (<0.001)
 Quadriceps 20.3 (16.4, 25.6) 59 % (35, 88) 69 0.14 (0.013)
 Ankle dorsiflexors 13.7 (10.6, 17.2) 62 % (42, 92) 57 0.13 (<0.001)
Table 3 Associations of physical functioning and health-related quality of life at 3 months after hospital discharge
ICU intensive care unit, LOS length of stay, APACHE Acute Physiology and Chronic Health Evaluation, SOFA Sequential Organ Failure Assessment, 6MWT 6-min walk test
a β-Coefficients (p value) modeled as univariate regression analyses. 6MWT and muscle strength modeled as percent predicted. β-Coefficients represent the percent 
change in the physical functioning variable per unit change in exposure variable
b Each domain of the EuroQol-5D questionnaire modeled as 0 “no problems” and 1 “any problems”
c Visual analog scale of the EQ-5D scores ranges from 0 to 10 based on patients perspective of current overall health
d The physical function domain is standardized to a 0–100 scale, and higher scores indicate better health-related quality of life
e Physical and mental composite scores of the short-form 36 survey, standardized to Canadian norms. Scores can range from 0 to 100 and are standardized to 50, 
which represents the average Canadian’s health-related quality of life
f Hospital Anxiety and Depression Scale (HADS), scores range from 0 to 21, significant symptoms of anxiety/depression defined as scores ≥8
Variable n = 50a 6-Minute walk test Grip Triceps Biceps Hamstrings Quadriceps Ankle dorsiflexors
EuroQol-5Db
 Mobility −0.211 (0.003) −0.297 (0.030) −0.223 (0.144) −0.228 (0.097) −0.283 (0.021) −0.252 (0.019) −0.140 (0.125)
 Self-care −0.177 (0.067) −0.132 (0.435) −0.170 (0.372) 0.165 (0.336) −0.198 (0.190) −0.177 (0.197) −0.142 (0.212)
 Usual activities −0.177 (0.006) −0.166 (0.153) −0.044 (0.736) −0.061 (0.606) −0.103 (0.335) −0.070 (0.446) −0.127 (0.105)
 Pain/discomfort −0.125 (0.031) −0.020 (0.855) −0.011 (0.929) −0.105 (0.345) −0.096 (0.359) −0.072 (0.412) −0.031 (0.688)
 Anxiety/depression −0.123 (0.079) −0.099 (0.476) −0.120 (0.421) −0.065 (0.630) −0.021 (0.866) −0.001 (0.994) −0.007 (0.941)
 Visual analog scalec 0.050 (0.025) 0.324 (0.428) 0.028 (0.534) 0.018 (0.662) 0.026 (0.480) −0.010 (0.759) −0.009 (0.746)
Short-from 36
 Physical functioningd 0.005 (0.001) 0.006 (0.019) 0.004 (0.178) 0.004 (0.112) 0.005 (0.026) 0.004 (0.062) 0.003 (0.063)
 Physical composite 
scoree
0.010 (0.001) 0.008 (0.185) 0.000 (0.997) 0.007 (0.266) 0.009 (0.105) 0.008 (0.113) 0.004 (0.320)
 Mental composite 
scoree
0.005 (0.118) 0.010 (0.128) 0.003 (0.712) 0.006 (0.409) 0.005 (0.416) 0.005 (0.308) 0.004 (0.453)
HADSf
 Anxiety −0.029 (0.001) −0.023 (0.176) −0.025 (0.179) −0.025 (0.130) −0.023 (0.123) −0.018 (0.16) −0.014 (0.251)
 Depression −0.016 (0.098) −0.033 (0.080) −0.008 (0.718) −0.023 (0.214) −0.012 (0.174) −0.027 (0.067) 0.010 (0.450)
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Univariate regression analysis showed that ICU LOS 
(p  =  0.002), number of days mechanically ventilated 
(p = 0.002), the presence of sepsis (p = 0.044) and corticos-
teroid use in the ICU (p = 0.019) were independently asso-
ciated with patient’s percent-predicted 6MWT distance 
(Table  4). Sepsis was the only ICU risk factor associated 
with a reduction in the 6MWT by an estimated 17 % and 
reductions in strength of all muscle groups (except quadri-
ceps). Muscle strength did not correlate with patient’s ICU 
or hospital LOS. Both the 6MWT and peripheral muscle 
strength did not show an association with the Functional 
Comorbidity Index, APACHE II or SOFA scores. There 
were no associations found between neuromuscular medi-
cation use or the presence of ARDS in the ICU and the 
6MWT, peripheral muscle strength or self-reported physi-
cal functioning (SF-36, EQ-5D) (data not shown).
The multivariate linear regression analysis assess-
ing predictors of 6MWT distance included the ICU risk 
factors that were statistically significant in the univari-
ate regression, with the exception of mechanical venti-
lation duration as it is highly correlated with ICU LOS. 
The presence of sepsis (β = −0.159, p = 0.030) and any 
corticosteroid use (β  =  −0.188, p  =  0.037) in the ICU 
were associated with patient’s age- and sex-matched 
6MWT distance (R2 = 0.24), and ICU LOS (β = −0.002, 
p =  0.233) was no longer statistically significant. Addi-
tionally, total cumulative steroid dose and average daily 
corticosteroid dose were analyzed in regression model 
and there was no association with physical function or 
muscle strength (data not shown).
Discussion
This is the first study to report the use of hand-held 
dynamometry assessment of multiple muscle groups in 
the general ICU survivor population. We demonstrated 
that approximately 3  months after hospital discharge 
the majority of ICU survivors experienced persistent 
muscle weakness across all muscle groups. The quadri-
ceps were the weakest muscle group measured, with the 
median percent-predicted strength achieved at 59  %. 
Fan et  al. [23] described grip strength in ARDS survi-
vors, in keeping with our results, reporting a range of 
50–70  % percent-predicted strength 3–12  months after 
ICU discharge. Global muscle weakness in ARDS survi-
vors, measured using MMT, has a reported prevalence 
between 8 and 22 % during the first year after discharge 
[23, 24]. However, we found that over 50 % of patients did 
not achieve 80 % of their age- and sex-matched predicted 
hand-held dynamometry-measured muscle strength. 
These differences may be due to the limited sensitiv-
ity of MMT to detect less severe weakness [24], or that 
our study included all ICU patients versus only ARDS 
patients.
A reduction in percent-predicted 6MWT distance 
and grip strength was associated with a decrease in the 
physical functioning domain on the SF-36 survey, simi-
lar to results found in prior studies [22–24]. We found 
that poor 6MWT performance was also associated with 
reduced HRQL in nearly all of the domains of the EQ-5D 
and SF-36, including the physical composite score, sug-
gesting there is a strong link between patients overall 
physical functioning and HRQL. Further supporting this 
finding, the muscle strength of patient’s was indepen-
dently associated with the patient’s perception of their 
mobility and general health on the SF-36. Poor 6MWT 
performance was associated with increased symptoms 
of anxiety, showing the connection between physi-
cal functioning and mental health [6]. It is important to 
note there was an expected association between mus-
cle strength and the 6MWT; however, the 6MWT was 
Table 4 Summary of predictors of muscle strength and physical functioning at 3 months after hospital discharge
ICU intensive care unit, LOS length of stay, APACHE Acute Physiology and Chronic Health Evaluation, SOFA Sequential Organ Failure Assessment, 6MWT 6-min walk test
a β-Coefficients (p value) modeled as univariate regression analyses. 6MWT and muscle strength modeled as percent predicted. β-Coefficients represent the percent 
change in the physical functioning variable per unit change in exposure variable
b Also analyzed using cumulative ICU and average daily corticosteroid dose with no significance found
Variable n = 50a 6-Minute walk test Grip Triceps Biceps Hamstrings Quadriceps Ankle dorsiflexors
ICU LOS, days −0.003 (0.041) −0.002 (0.85) −0.010 (0.305) −0.005 (0.537) −0.001 (0.806) 0.000 (0.922) −0.001 (0.685)
Hospital LOS, days −0.003 (0.079) −0.001 (0.965) 0.002 (0.727) 0.003 (0.498) 0.000 (0.969) 0.003 (0.274) 0.001 (0.755)
Mechanical ventilation, 
days
−0.004 (0.045) −0.001 (0.905) −0.009 (0.378) −0.004 (0.610) −0.001 (0.899) 0.001 (0.809) −0.001 (0.742)
Presence of sepsis −0.168 (0.029) −0.389 (0.009) −0.328 (0.045) −0.315 (0.033) −0.328 (0.016) −0.134 (0.262) −0.197 (0.049)
APACHE II score −0.003 (0.642) −0.002 (0.868) −0.008 (0.515) 0.003 (0.802) 0.003 (0.755) 0.011 (0.212) 0.006 (0.397)
SOFA score 0.011 (0.257) 0.022 (0.229) 0.021 (0.325) 0.027 (0.167) 0.020 (0.219) 0.019 (0.174) 0.017 (0.154)
Functional Comorbidity 
Index
−0.019 (0.593) −0.070 (0.247) −0.111 (0.114) −0.050 (0.437) −0.000 (0.998) 0.013 (0.803) −0.044 (0.274)
Any corticosteroid useb −0.215 (0.019) −0.304 (0.092) −0.382 (0.062) −0.359 (0.052) −0.320 (0.047) −0.222 (0.137) −0.221 (0.058)
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associated with more domains of HRQL than muscle 
strength alone. This finding highlights that the 6MWT 
accounts for more than just physical functioning or mus-
cle strength, and is a composite assessment that may also 
be influenced by cardiopulmonary status, mental health, 
motivation, neurological status and bodily pain [24, 44, 
45].
ICU LOS is thought to be a surrogate marker for 
immobility [23]. This is a well-described risk factor for 
muscle wasting and weakness in both healthy controls 
and patients in ICU [10, 46]. However, in our multivariate 
regression analysis ICU LOS was not found to be a pre-
dictor of muscle strength or 6MWT. The model included 
both corticosteroid use and the presence of sepsis, sug-
gesting that ICU LOS, an indicator of immobility, may be 
confounded or collinearly correlated by these variables. 
Therefore, interventions to reduce immobility in the ICU 
may not decrease the prevalence of long-term impaired 
muscle strength or physical functioning. However, the 
benefits of interventions such as early mobilization still 
need to be examined in long-term randomized controlled 
trials using the appropriate physical outcome measures 
[47–50].
The presence of sepsis during critical illness was signifi-
cantly associated with both impaired physical function-
ing and muscle weakness in nearly all muscle groups (the 
most of any ICU risk factor) as part of the univariate and 
multivariate linear regression analysis. Systemic inflam-
mation and cytokine release have been shown to induce 
muscle injury and increase the incidence of ICUAW 
detected in the ICU [7, 51–53]. Our findings support a 
premise that inflammation during critical illness can 
result in long-term detectable impairment of muscle 
function [3]. Our study suggests sepsis, as a mechanism 
possibly related to the acute systemic inflammatory pro-
cess, may be more important than ICU LOS or immobil-
ity in long-term physical impairment.
Our analysis showed that any exposure to corticos-
teroid use during critical illness was associated with 
reduced physical functioning. This supports the findings 
of prior studies in ARDS survivors and recommendations 
to avoid corticosteroid use in the ICU in order to lessen 
the degree of patient’s long-term functional disability [5, 
10, 24]. We did not see any effect on physical function-
ing when analyzing average daily corticosteroid dose or 
cumulative dose, similar to other studies [10]. Prior stud-
ies examining the effects of corticosteroids were limited 
to patients who had ARDS, but surprisingly none of our 
patients who had ARDS (23 %) received any corticoster-
oids. This highlights the variability of clinical practice 
across institutions and the importance of studying long-
term physical functioning outcomes across the general 
ICU population.
The limitations of this study include that it is a single-
center study with a relatively small sample size. Addi-
tionally, patient recruitment was limited due to the small 
capacity of the follow-up clinic. Patients who may have 
met inclusion criteria were not screened, potentially 
creating selection bias. However, patient selection was 
random and we had a relatively few number of patients 
decline enrollment or who were lost to follow-up.
Conclusion
We found that in survivors of critical illness approxi-
mately 3  months after hospital discharge patients had 
significant impairment in muscle strength and physical 
functioning measured using hand-held dynamometry 
and the 6MWT. Patients with impaired physical func-
tioning and muscle weakness were found to have reduced 
HRQL. Sepsis and corticosteroid use were found to be 
an important risk factor for reduced long-term physi-
cal function, whereas ICU length of stay (a surrogate for 
immobility) was not.
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